The U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar in adults with type 2 diabetes mellitus.
FDA approves new obesity drug from Eli Lilly named Zepbound washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
Laxative misuse is cropping up in wellness and weight-loss social media communities— and some experts are concerned about its close ties to eating disorders
New research found that exercising in the morning may be more helpful for managing weight. Researchers theorize that this is because a fasted workout working out on an empty stomach can reduce glucose levels, which results in the body turning to fat oxidation for energy.